GLUD1 and renal carcinoma: Previous work revealed that high expression of glutamate dehydrogenase 1 (GLUD1) is detrimental to the survival of renal cancer cells in unfavorable nutritional environments (such as amino acid deficiency) and is significantly associated with good prognosis in KIRC patients [18].